Ten Bay Bio, Inc. — Form D/A
Ten Bay Bio, Inc. of MILWAUKEE, WI, a company, filed a Form D amendment with the SEC on 2025-05-13. The offering totals $11.5M, of which $11.5M was reported sold. Industry: Other.
Offering
- Filed: 2025-05-13
- Form: D/A
- Accession: 0002032513-25-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $11.5M
- Amount sold: $11.5M
- Investors: 6
- Date of first sale: 2024-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-520719
Issuer
- Name: Ten Bay Bio, Inc.
- CIK: 0002032513
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 4816 W. WISCONSIN AVENUE, MILWAUKEE, WI, 53208
- Phone: (262) 492-5557
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Casey Cunningham | Director | Milwaukee, WI |
| Andrew Kadlec | Director | Milwaukee, WI |
| Omar Khalil | Director | Milwaukee, WI |
| Tim Mayleben | Director | Plymouth, MI |
| Paul Weiss | Director | Milwaukee, WI |
| Andrew Kadlec | Executive Officer | Milwaukee, WI |
Other filings by this issuer (1)
More